Oncotarget cover image

Oncotarget

Trending With Impact: Dual Requirement in Stem Cell Leukemia/Lymphoma

May 18, 2022
The podcast discusses the impact of chromosomal translocations in cancer, focusing on the BCR-FGFR1 fusion protein in SCLL. They explore the necessary interactions of GRB2 and PLC Gamma-1 for cell proliferation and potential therapeutic interventions in BCR-FGFR1-driven hematologic malignancies.
07:20

Podcast summary created with Snipd AI

Quick takeaways

  • Chromosomal translocations can lead to aberrant cell proliferation and cancer through mutations during cell division.
  • BCR-FGFR1-driven 8p11 cell proliferation requires Grb2 and PLCγ1 interactions for biological activity and targeted inhibitors show promise in treatment of hematologic malignancies.

Deep dives

Chromosomal Translocations and Oncogenic Proteins

Chromosomes, found in the nucleus of cells, contain DNA strands. During cell division, chromosomal translocations can occur, leading to mutations that may cause aberrant cell proliferation and cancer. Oncogenic proteins resulting from chromosomal translocations, like BCR FgFR1, can drive diseases such as Stemsoleukemia-Lymphoma by affecting cell signaling pathways.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner